Terms: = Bone cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Treatment
50 results:
1. Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus.
Doglio M; Ugolini A; Bercher-Brayer C; Camisa B; Toma C; Norata R; Del Rosso S; Greco R; Ciceri F; Sanvito F; Casucci M; Manfredi AA; Bonini C
Nat Commun; 2024 Mar; 15(1):2542. PubMed ID: 38538608
[TBL] [Abstract] [Full Text] [Related]
2. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
[TBL] [Abstract] [Full Text] [Related]
3. Tumor Growth Rate in Spinal Giant Cell Tumors of bone and Association With the Immune Microenvironment and Denosumab treatment Responsiveness: A Multicenter Study.
Zheng BW; Zheng BY; Niu HQ; Yang YF; Zhu GQ; Li J; Zhang TL; Zou MX
Neurosurgery; 2023 Mar; 92(3):524-537. PubMed ID: 36409294
[TBL] [Abstract] [Full Text] [Related]
4. Immunosuppressive Effects and Potent Anti-tumor Efficacy of mTOR Inhibitor Everolimus in Breast Tumor-bearing Mice.
Rostamzadeh D; Haghshenas MR; Samadi M; Mojtahedi Z; Babaloo Z; Ghaderi A
Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):287-299. PubMed ID: 35822679
[TBL] [Abstract] [Full Text] [Related]
5. Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer.
Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
Bioengineered; 2022 Jan; 13(1):1942-1951. PubMed ID: 35019820
[TBL] [Abstract] [Full Text] [Related]
6. CML derived exosomes promote tumor favorable functional performance in T cells.
Jafarzadeh N; Gholampour MA; Alivand MR; Kavousi S; Arzi L; Rad F; Sadeghizadeh M; Pornour M
BMC Cancer; 2021 Sep; 21(1):1002. PubMed ID: 34493241
[TBL] [Abstract] [Full Text] [Related]
7. Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatment.
Toda Y; Kohashi K; Yamamoto H; Ishihara S; Ito Y; Susuki Y; Kawaguchi K; Kiyozawa D; Takamatsu D; Kinoshita I; Yamada Y; Maehara J; Kimura A; Tamiya S; Taguchi K; Matsunobu T; Matsumoto Y; Nakashima Y; Mawatari M; Oda Y
Sci Rep; 2021 Jul; 11(1):14821. PubMed ID: 34285260
[TBL] [Abstract] [Full Text] [Related]
8. Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
Mondello P; Fama A; Larson MC; Feldman AL; Villasboas JC; Yang ZZ; Galkin I; Svelolkin V; Postovalova E; Bagaev A; Ovcharov P; Varlamova A; Huet S; Tesson B; McGrath KR; Slager S; Link BK; Syrbu S; Novak AJ; Habermann TM; Witzig TE; Nowakowski GS; Salles G; Cerhan JR; Ansell SM
Blood Cancer J; 2021 Jul; 11(7):130. PubMed ID: 34267181
[TBL] [Abstract] [Full Text] [Related]
9. Relative expression and prognostic significance of forkhead box P3 in childhood B-cell acute lymphoblastic leukemia.
Abdelhafeez HEA; Hamid FFA; Hassan NM; Assem MM; Soliman AF
Pediatr Blood Cancer; 2021 Oct; 68(10):e29129. PubMed ID: 34133057
[TBL] [Abstract] [Full Text] [Related]
10. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
[TBL] [Abstract] [Full Text] [Related]
11. Effect of systemic steroid therapy in Graves' orbitopathy on regulatory T cells and Th17/Treg ratio.
Siomkajło M; Mizera Ł; Szymczak D; Kolačkov K; Grzegrzółka J; Bolanowski M; Daroszewski J
J Endocrinol Invest; 2021 Nov; 44(11):2475-2484. PubMed ID: 33866536
[TBL] [Abstract] [Full Text] [Related]
12. Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma.
Lee L; Alrasheed N; Khandelwal G; Fitzsimons E; Richards H; Wilson W; Chavda SJ; Henry J; Conde L; De Massy MR; Chin M; Galas-Filipowicz D; Herrero J; Chain B; Quezada SA; Yong K
Front Immunol; 2021; 12():618610. PubMed ID: 33717112
[TBL] [Abstract] [Full Text] [Related]
13. Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma.
Zhou X; Wu J; Duan C; Liu Y
J Immunol Res; 2020; 2020():7890985. PubMed ID: 33062726
[TBL] [Abstract] [Full Text] [Related]
14. Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses.
Thangavelu G; Wang C; Loschi M; Saha A; Osborn MJ; Furlan SN; Aoyama K; McDonald-Hyman C; Aguilar EG; Janesick AS; Chandraratna RA; Refaeli Y; Panoskaltsis-Mortari A; MacDonald KP; Hill GR; Zeiser R; Maillard I; Serody JS; Murphy WJ; Munn DH; Blumberg B; Brown C; Kuchroo V; Kean LS; Hippen KL; Noelle RJ; Blazar BR
Blood; 2021 Feb; 137(8):1090-1103. PubMed ID: 32976550
[TBL] [Abstract] [Full Text] [Related]
15. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract] [Full Text] [Related]
16. Mesenchymal Stem/Stromal Cells Derived from Dental Tissues: A Comparative In Vitro Evaluation of Their Immunoregulatory Properties Against T cells.
De la Rosa-Ruiz MDP; Álvarez-Pérez MA; Cortés-Morales VA; Monroy-García A; Mayani H; Fragoso-González G; Caballero-Chacón S; Diaz D; Candanedo-González F; Montesinos JJ
Cells; 2019 Nov; 8(12):. PubMed ID: 31766697
[TBL] [Abstract] [Full Text] [Related]
17. Functional reprogramming of regulatory T cells in the absence of foxp3.
Charbonnier LM; Cui Y; Stephen-Victor E; Harb H; Lopez D; Bleesing JJ; Garcia-Lloret MI; Chen K; Ozen A; Carmeliet P; Li MO; Pellegrini M; Chatila TA
Nat Immunol; 2019 Sep; 20(9):1208-1219. PubMed ID: 31384057
[TBL] [Abstract] [Full Text] [Related]
18. Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile.
Zhao Q; Hu J; Mitra A; Cutrera J; Zhang W; Zhang Z; Yan J; Xia X; Mahadeo KM; Livingston JA; Gorlick R; Li S
J Immunother Cancer; 2019 Jun; 7(1):154. PubMed ID: 31208461
[TBL] [Abstract] [Full Text] [Related]
19. Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients.
Meyer EH; Laport G; Xie BJ; MacDonald K; Heydari K; Sahaf B; Tang SW; Baker J; Armstrong R; Tate K; Tadisco C; Arai S; Johnston L; Lowsky R; Muffly L; Rezvani AR; Shizuru J; Weng WK; Sheehan K; Miklos D; Negrin RS
JCI Insight; 2019 May; 4(10):. PubMed ID: 31092732
[TBL] [Abstract] [Full Text] [Related]
20. Systemic Antibiotic Therapy Reduces Circulating Inflammatory Dendritic Cells and Treg-Th17 Plasticity in Periodontitis.
Rajendran M; Looney S; Singh N; Elashiry M; Meghil MM; El-Awady AR; Tawfik O; Susin C; Arce RM; Cutler CW
J Immunol; 2019 May; 202(9):2690-2699. PubMed ID: 30944162
[TBL] [Abstract] [Full Text] [Related]
[Next]
